SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-028396
Filing Date
2020-10-15
Accepted
2020-10-15 19:52:41
Documents
2
Period of Report
2020-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5200
2 EX-24 DOCUMENT attachment1.htm EX-24 4744
  Complete submission text file 0000899243-20-028396.txt   11516
Mailing Address C/O ARCH VENTURE PARTNERS 999 THIRD AVENUE, SUITE 3400 SEATTLE WA 98104
Business Address C/O ARCH VENTURE PARTNERS 999 THIRD AVENUE, SUITE 3400 SEATTLE WA 98104 857-400-4222
Codiak BioSciences, Inc. (Issuer) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CODIAK BIOSCIENCES, INC. 35 CAMBRIDGEPARK DRIVE, SUITE 500 CAMBRIDGE MA 02140
Business Address
Sorensen Benny (Reporting) CIK: 0001828516 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39615 | Film No.: 201242470